Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Virginia M. Kelly
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy With Oncolytic HSV-1 M002
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
CD133 Marks a Myogenically Primitive Subpopulation in Rhabdomyosarcoma Cell Lines That Are Relatively Chemoresistant but Sensitive to Mutant HSV
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Related publications
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Current Pharmaceutical Biotechnology
Biotechnology
Pharmaceutical Science
Oncolytic Virotherapy
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
Targeting Pediatric Cancer Stem Cells With Oncolytic Virotherapy
Pediatric Research
Child Health
Pediatrics
Perinatology
Delivery and Biosafety of Oncolytic Virotherapy
Frontiers in Oncology
Cancer Research
Oncology
Undifferentiated Pleomorphic Sarcoma
412. The Efficacy and Bio-Distribution of Oncolytic HSV-1 (G47Δ) in Mouse Orthotopic Esophageal Cancer Models
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy
Cancer immunology research
Cancer Research
Immunology
Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances
Oncolytic Virotherapy
Overcoming the Limitations of Locally Administered Oncolytic Virotherapy
BMC Biomedical Engineering
